AxoGen (NASDAQ:AXGN) used its presentation at the 47th annual Raymond James Institutional Investors Conference to outline its mission to make restoration of peripheral nerve function an expected ...
Iovance Biotherapeutics developed Amtagvi, a medicine manufactured from patients' own cancer-fighting cells. Amtagvi earned approval for melanoma in early 2024. Although the stock has not performed ...
JD.com (NasdaqGS:JD) has partnered with 12 hardware brands to create a new virtual idol girl group called "十二姬". The group is ...
The raging Iran war, which has spread across the Middle East and beyond, entered its seventh day Friday after Israeli forces ...
"I saw my company discard half of my peers and double my pay," the former Block employee wrote. "That's not an honor. It ...
Stock market today: Dow, S&P 500, Nasdaq futures climb with key jobs report set to cap volatile week
Stock markets continue to be dominated by developments in the Middle East as the major gauges are on track for a week of losses.
Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced that it intends to ...
Sales jumped 9%, and membership fees rose 14% — another quarter where Costco turned traffic and subscriptions into the kind of steady growth most retailers are chasing ...
Even as theme park behemoths such as Disney and Universal are seeing fairly strong visitor numbers, many smaller parks or even chains have struggled amid lower consumer sentiment and an uncertain ...
The UFC’s owners at TKO Group Holdings announced dividend payouts to stockholders for the first quarter of 2026 that should ...
Palantir (PLTR) is among the favorite stocks for investors to trade right now, and there are good reasons for such a view.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results